Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...

While HHS Secretary Kennedy frets over food dye in Froot Loops, his 2023 attack on Gardasil — a vaccine proven to prevent ...

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...

Merck unveiled encouraging Phase 3 KEYNOTE-689 trial results for KEYTRUDA at the AACR 2025 Meeting, sparking investor ...

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

Market volatility has led to compelling dividend opportunities, and Merck and Schlumberger offer great value at low PE ratios ...

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors may exit the stock.

Additionally, the company’s Animal Health division reported strong 13% growth. Sales of GARDASIL, however, fell 18% as a result of shipments to China being halted due to high inventory levels at ...

Robert F. Kennedy Jr. and I rarely see eye to eye, but I’ll grudgingly admit he’s not entirely wrong about food dyes, though ...

Find insight on Merck, Sanofi and more in the latest Market Talks covering the Health Care sector.

Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, Gardasil.